Pathogenesis of cytomegalovirus-associated pneumonitis in ICR mice: possible involvement of superoxide radicals

por Ikeda, T., Shimokata, K., Daikoku, T., Fukatsu, T., Tsutsui, Y., Nishiyama, Y.
Publicado 1992

Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.

por Ando, Y., Minami, H., Saka, H., Ando, M., Sakai, S., Shimokata, K.
Publicado 1997

Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.

por Hasegawa, T., Isobe, K., Tsuchiya, Y., Oikawa, S., Nakazato, H., Nakashima, I., Shimokata, K.
Publicado 1993

Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer [seecomments]

por Yokoyama, A., Kurita, Y., Saijo, N., Tamura, T., Noda, K., Shimokata, K., Matsuda, T.
Publicado 1998

Establishment and characterisation of human carcinoembryonic antigen transgenic mice.

por Hasegawa, T., Isobe, K., Tsuchiya, Y., Oikawa, S., Nakazato, H., Ikezawa, H., Nakashima, I., Shimokata, K.
Publicado 1991

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer

por Ando, M, Ando, Y, Hasegawa, Y, Shimokata, K, Minami, H, Wakai, K, Ohno, Y, Sakai, S
Publicado 2001

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

por Suzuki, R, Hasegawa, Y, Baba, K, Saka, H, Saito, H, Taniguchi, H, Yamamoto, M, Matsumoto, S, Kato, K, Oishi, T, Imaizumi, K, Shimokata, K
Publicado 2006